Journal of the Korean Ophthalmological Society 1998;39(2):285-291.
Published online February 1, 1998.
Introduction of a New Therapeutic Modality for the Chronic Behcets Disease Patients: Synchronization of Plasmapheresis with Immune Modulation Therapy-.
Song Hak Kim, Suk Dong Kim
Department of Ophthalmology, Holy Family Hospital, The Catholic University of Korea, Puchun, Korea.
만성 베체트병 환자에 대한 새로운 치료모델의 제시 - 혈장반출법을 이용한 면역 조절요법 -
김송학(Song Hak Kim),김석동(Suk Dong Kim)
Abstract
The Behcets disease patients with uveitis are oftern suffering from chronic recurrent inflammation resulting in the blindness. Etiology, prognosis, treatment modalities of this disease are various, and the factors, affecting the chronic long term prognosis are not clearly identified. Current treatment for Behcets disease is combination therapy : steroid with colchicine, cyclophosphamide, or cyclosporin. But these kinds of treatment was insufficient to change the disease process and often produced severe complications. Authors treated 4 cases of Behcets patients who had chronic progressive steroid resistent uveitis, with synchronizatin of plasmapheresis and immune modulation therapy. All of them showed marked improvement in uveal inflammatory reaction and visual acuity.
Key Words: Behcets disease;Plasmapheresis;Immune modulation
TOOLS
METRICS Graph View
  • 395 View
  • 4 Download
Related articles


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next